Concord Medical Services Holdings (FRA:C2C) Total Inventories: €5.57 Mil (As of Dec. 2025)


FRA:C2C Concord Medical Services Holdings Ltd FRA:C2C
51 GF Score
Price €6.25
GF Value €9.81
! 6 Warning Signs
View Full Analysis

What is Concord Medical Services Holdings Total Inventories?

Concord Medical Services Holdings FRA:C2C 51 Total Inventories is €5.57 Mil as of Dec. 2025. GuruFocus rates FRA:C2C with a GF Score™ of 51/100 and a GF Value™ of €9.81. The stock has 6 warning signs investors should review.

Concord Medical Services Holdings's total inventories for the quarter that ended in Dec. 2025 was €5.57 Mil. Concord Medical Services Holdings's average total inventories from the quarter that ended in Jun. 2025 to the quarter that ended in Dec. 2025 was €3.61 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Concord Medical Services Holdings's Net-Net Working Capital per share for the quarter that ended in Dec. 2025 was €-231.69.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Concord Medical Services Holdings's Days Inventory for the six months ended in Dec. 2025 was 23.66.

Inventory Turnover measures how fast the company turns over its inventory within a year. Concord Medical Services Holdings's Inventory Turnover for the quarter that ended in Dec. 2025 was 7.71.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Concord Medical Services Holdings's Inventory-to-Revenue for the quarter that ended in Dec. 2025 was 0.11.


Concord Medical Services Holdings  (FRA:C2C) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Concord Medical Services Holdings's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2025 is

Net-Net Working Capital Per Share (Q: Dec. 2025 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(36.107+0.75 * 5.341+0.5 * 5.573-569.549
-0-479.335)/4.342
=-231.69

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Concord Medical Services Holdings's Days Inventory for the six months ended in Dec. 2025 is calculated as:

Days Inventory=Average Total Inventories (Q: Dec. 2025 )/Cost of Goods Sold (Q: Dec. 2025 )*Days in Period
=3.613/27.863*365 / 2
=23.66

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Concord Medical Services Holdings's Inventory Turnover for the quarter that ended in Dec. 2025 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Dec. 2025 ) / Average Total Inventories (Q: Dec. 2025 )
=27.863 / 3.613
=7.71

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Concord Medical Services Holdings's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Dec. 2025 ) / Revenue (Q: Dec. 2025 )
=3.613 / 31.513
=0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


Concord Medical Services Holdings Total Inventories Related Terms


Concord Medical Services Holdings Total Inventories Historical Data

* Premium members only.

The historical data trend for Concord Medical Services Holdings's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Concord Medical Services Holdings Total Inventories Chart

Concord Medical Services Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Inventories
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.29 11.49 5.18 4.39 5.57

Concord Medical Services Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.18 5.10 4.39 1.65 5.57
FRA:C2C
51GF Score
Concord Medical Services Holdings Ltd FRA:C2C
Total Inventories is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Concord Medical Services Holdings Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Frequently Asked Questions Learn more about Total Inventories →
What does a Total Inventories of €5.57 Mil mean?
Concord Medical Services Holdings (FRA:C2C) has a Total Inventories of €5.57 Mil as of Dec. 2025. The total amount of inventory as recorded on a company's balance sheet. View historical data for Concord Medical Services Holdings and its competitors.
Is Concord Medical Services Holdings' Total Inventories too high?
Concord Medical Services Holdings' current Total Inventories is €5.57 Mil. Overall, Concord Medical Services Holdings has a GF Score™ of 51/100, reflecting its overall financial health beyond just this single metric.
How does Concord Medical Services Holdings' Total Inventories compare to CCEL and GBCS?
Concord Medical Services Holdings' Total Inventories of €5.57 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Healthcare Providers & Services company?
A good Total Inventories depends on the Healthcare Providers & Services industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Concord Medical Services Holdings and its competitors. Concord Medical Services Holdings's current Total Inventories is €5.57 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Concord Medical Services Holdings stock overvalued right now?
Concord Medical Services Holdings (FRA:C2C) has a current Total Inventories of €5.57 Mil. The stock's GF Value™ is €9.81, compared to a current price of €6.25 — trading 36.3% below its estimated fair value. The current Total Inventories is €5.57 Mil. Concord Medical Services Holdings' overall GF Score™ is 51/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Concord Medical Services Holdings (FRA:C2C), the current Total Inventories is €5.57 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Concord Medical Services Holdings (FRA:C2C) Overvalued in 2026?

Based on GuruFocus' analysis, Concord Medical Services Holdings stock appears to be undervalued. The current stock price of €6.25 is trading 36.3% below its estimated GF Value™ of €9.81.

Key valuation signals for FRA:C2C:

  • Total Inventories: €5.57 Mil
  • GF Value™: €9.81 vs. price of €6.25 (36.3% below fair value)
  • GF Score™: 51/100 with 6 warning signs

No single metric tells the full story. See the FRA:C2C stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Concord Medical Services Holdings Business Description

Other Exchanges CCM:USA
Address Hanwei Plaza Building, No. 7 Guanghua Road, Room A1-A5, 26th Floor, East Area, Chaoyang District, Beijing, CHN, 100020
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Geographically, the company derives revenue from PRC.
51GF Score

Get the complete analysis for FRA:C2C

Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.25
Price
€9.81
GF Value